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IntroductIon
Sleep and its functional interaction with 
immune system is well recognized (Majde 
and Krueger, 2005; Krueger and Majde, 
2011). Sleep synchronized changes in brain 
activity are implicated in direct rather than 
indirect immune function (Bryant et al., 
2004). Sleep or at least its homeostatic 
component has been suggested to have an 
active auto-regulatory and/or auto-mod-
ulatory mechanism (Krueger et al., 2008; 
Kumar, 2010). This mechanism operates 
through adenosine and other sleep regu-
lating substances (SRSs) like interleukin-1 
beta (IL-1β), tumor necrosis factor-alpha 
(TNF-α), growth-hormone-releasing hor-
mone (GHRH), corticotropin-releasing 
hormone (CRH), nitric oxide (NO), pros-
taglandin D
2
 (PGD2), etc. These SRSs are 
most likely the connecting link between 
sleep and immune system (Krueger et al., 
2008). The issue of peripheral cytokines 
affecting brain signaling in sleep has been 
reviewed comprehensively with three sug-
gested routes for transfer of peripheral 
cytokines to the brain (Krueger and Majde, 
2003). These routes may also be involved in 
transfer and hence in transmitting the sig-
nals from peripheral SRSs. Sleep–immune 
system co-relations has been investigated 
across a wide range of immune parameters 
out of which cytokines, immune cells, anti-
bodies, and neuro-endocrine system consti-
tute the focal group. Human sleep loss (SL) 
models have been of great help in mecha-
nistic characterization of cytokines (IL-1β 
and TNF-α role) in sleep and neuroendo-
crine components (GHRH and CRH) in 
non-REM sleep, respectively (Majde and 
Krueger, 2005; Krueger and Majde, 2011). 
The paradigm has helped establish sleep’s 
functional characterization because of prac-
tical simplicity (Reynolds and Banks, 2010) 
and often non-ambiguous results. However, 
there may be certain limitations with SL 
model in context of result translation per-
taining to different parameter patterns. The 
comment has been surmised to highlight 
these challenges which may give direction 
to future research in minimizing the vari-
able factors. It may also help to compare the 
results from available literature objectively.
Sleep loSS model: advantageS and 
challengeS
Sleep loss is one of the models which have 
been employed to study sleep–immune sys-
tem inter-relationship. It is subdivided into 
three categories namely total sleep depri-
vation (TSD), chronic sleep restriction/
partial sleep deprivation (PSD), and sleep 
fragmentation/disruption. TSD (both acute 
and chronic variations) and PSD have been 
used widely, however, sleep disruption has 
been very rarely employed (Reynolds and 
Banks, 2010). Human SL model has helped 
in establishing sleep–immune interaction 
and is practically hassle free in planning. 
The outcomes of these studies have usu-
ally been non-ambiguous. Various groups 
have reported similar trends with dispari-
ties, mainly because of differences in SL 
design (Majde and Krueger, 2005; Krueger 
and Majde, 2011). For instance, sTNF-
R p55 level did not alter on PSD (Haack 
et al., 2007; Boudjeltia et al., 2008) but it 
increased on three nights of TSD (Haack 
et al., 2007). Sometimes, PSD and acute 
TST (one/two night) studies have yielded 
similar trends like in case of white blood 
cell (WBC; Dinges et al., 1994; Boudjeltia 
et al., 2008; Liu et al., 2009), neutrophil 
(Boudjeltia et al., 2008; Liu et al., 2009), and 
serum IL-1β (Frey et al., 2007; van Leeuwen 
et al., 2009).
Human sleep deprivation studies have 
been asserted not to have the problem 
of stress-induced forced wakefulness as 
is done in animal experiments (Dinges 
et al., 1994; Redwine et al., 2004; Krueger 
and Majde, 2011). There was no behavio-
ral/physiological symptom of stress after 
one night of TSD, though there was some 
evidence of neurobehavioral stress after 
63 h without sleep (Dinges et al., 1994). 
The study has quoted seven articles on 
glucocorticoid–SL interaction pattern 
and concluded that SL without physical/
mental demand is not affected by stress in 
laboratory conditions. The study further 
illustrated an increase in peripheral total 
WBC, granulocytes, monocytes, and natu-
ral killer cells activity with striking consist-
ency, irrespective of gender, race, or time 
of the year (Dinges et al., 1994). However, 
a more recent article cited non-uniform-
ity (TSD effect) on cortisol pattern, with 
three studies reporting an increase, three 
reporting a decrease, and seven reporting 
no change. It also reported a significant 
increase in subjective stress with 40 h TSD 
(Frey et al., 2007). Moreover, the co-rela-
tionship between stress and blood pres-
sure (Gasperin et al., 2009) and increase 
in blood pressure on TSD with different SL 
designs has been reported by three stud-
ies (Meier-Ewert et al., 2004). Similarly, 
increase in heart rate, suggesting stress 
during PSD, has also been reported (van 
Leeuwen et al., 2009). The inconclusive-
ness of the evidences vis-a-vis cortisol 
pattern and SL; subjective stress and SL; 
and stress–blood pressure–SL leave little 
to doubt about elusiveness of consensus 
on the issue of stress–SL interaction. Most 
importantly, there is very significant gap 
in the literature in terms of SL study data 
of children, adolescent, and elderly. It is 
may be more than interesting for future 
studies to delve into the dimension, which 
may open new dimension in context of SL 
effect on stress marker(s).
Many other elements have also been 
implicated by other groups to affect the 
immune variables during SL studies. The 
duration of SL, circadian phase, posture 
control, light exposure, blood sampling fre-
quency, nutrition (type and timing), assay 
sensitivity, body mass index (BMI), and obe-
sity may limit comparability of SL results. 
These factors were enumerated to explain 
the disparities in reports of  interleukin-6 
(IL-6), C-reactive protein (CRP), and cor-
tisol outcome by different groups (Frey 
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et al., 2007). The blood samplings through 
intravenous catheter limit the investiga-
tion of diurnal variations in immune func-
tions. The intravenous catheter induces 
local alterations in cytokines and soluble 
cytokine receptors production (Haack et al., 
2000). IL-6 level increased with the use of 
an intravenous catheter across 24 h regard-
less of sleep deprivation (Haack et al., 2002). 
The volunteer age and gender had also been 
shown and/or indicated to affect sleep dep-
rivation effect on some immune variables. 
The activation of cellular inflammation 
markers (IL-6 and TNF-α) on PSD is gender 
dependent (Irwin et al., 2010). The contrast-
ing pattern of monocyte in young men and 
postmenopausal women may be attributed 
to age and gender (Boudjeltia et al., 2008). 
The likely influence of sleep deprivation on 
melatonin amplitude has been described 
with the possible involvement of age (Zeitzer 
et al., 2007). The finding is very important 
because melatonin and its’ rhythm dynamics 
has intricate co-relationship with cortisol, 
catecholamine, and other rhythm markers 
(Manzar and Hussain, 2011). This may have 
entailments for circadian pattern of immune 
parameter and their variations with SL 
designs. PSD decreased Mac-1 positive lym-
phocytes; and increased L-selectin positive 
lymphocytes and monocytes. However, the 
differences were discernible at 06:30 h and 
not at 03:00 hours. This may reflect more 
of sleep rebound (homeostatic-sleep expres-
sion) than PSD effect (Redwine et al., 2004).
The auto-regulatory/auto-modulatory 
characteristic of sleep and/or its homeo-
static part (Krueger et al., 2008; Kumar, 
2010) operate through adenosine and other 
SRSs like IL-1β, TNF-α, GHRH, CRH, NO, 
PGD2, etc. The majority of these media-
tors are either cytokine or endocrine com-
ponents. The colligating attribute of SRSs 
in the sleep–immune interplay has been 
described (Krueger et al., 2008). The indi-
cation of three routes for transfer and hence 
transmittance of peripheral (production 
site) SRSs borne signal to brain foregrounds 
the sleep–immune system relation (Krueger 
and Majde, 2003). Sleep regulation depends 
on the interplay of three elements namely 
circadian, homeostatic, and allostatic com-
ponents (Saper et al., 2005). Their involve-
ment in SL study results have been connoted 
and/or evidenced (Redwine et al., 2004; 
McEwen, 2006; Zeitzer et al., 2007). Hence, 
it is advisable to keep these generalizations 
in consideration during comparison of 
SL study results and/or designing future 
studies:
(i) Interaction between specific SL design 
with circadian, homeostatic, and allo-
static characteristic of sleep.
(ii) Implications for the rhythm dynamics 
of immune parameter being investi-
gated with the design of SL study.
(iii) The differences in design of TSD, 
PSD, and sleep disruption studies 
from different laboratories.
Furthermore, there are some studies 
which suggest inhibition of hippocampal 
neurogenesis, independent of adrenal stress 
hormones on prolonged SL, with the pos-
sibility of cognitive dysfunction and mood 
disorders. Even, modest sleep restriction 
may interfere with neurogenesis enhance-
ment associated with learning processes 
(Meerlo et al., 2009). Future studies should 
address the ethical issues of exposing the 
volunteers to chronic SL and appropriate 
remedial management like cognitive func-
tion assessment and mood analysis tests.
The opinion highlighted the advan-
tages like practical simplicity; often non- 
ambiguous results, lack of consensus on the 
issue of stress non-interference, important 
gap in literature on stress–SL interaction, 
challenges complicating generality, and 
future directions. All factors implicated to 
affect the result should be taken into consid-
eration while comparing results from other 
and/or older studies. The opinion may give 
directions to future studies to minimize and/
or clearly report about outcomes affecting 
factors in literature; filling in of literature 
gap; and some ethical management.
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